T80.39 Other ABO incompatibility reaction due to transfusion of blood or blood products

Name of the Condition

• Other ABO incompatibility reaction due to transfusion of blood or blood products.

Summary

This condition describes an adverse immune reaction resulting from the transfusion of blood or blood products with incompatible ABO antigens. It is a serious complication that can lead to hemolysis, organ dysfunction, and systemic effects. The reaction occurs when pre-existing antibodies in the recipient target antigens on the transfused blood cells, triggering an immune response.

Causes

ABO incompatibility reactions are caused by the transfusion of blood or blood products that do not match the recipient's ABO blood type. This mismatch leads to the destruction of transfused red blood cells by the recipient's antibodies, resulting in hemolysis. Errors in blood typing, crossmatching, or administration can contribute to this complication.

Risk Factors

• Transfusion of blood products without proper ABO typing or crossmatching
• Emergency transfusions where typing may be delayed
• Human error in blood product labeling or administration
• Use of pooled plasma products with mixed ABO types
• Transfusion of platelets or plasma from donors with incompatible ABO antigens

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Dyspnea or respiratory distress
• Jaundice or pallor
• Nausea, vomiting, or abdominal pain

Diagnosis

Diagnosis involves clinical assessment of symptoms, laboratory testing to detect hemolysis (e.g., elevated bilirubin, decreased haptoglobin, hemoglobinuria), and confirmation of ABO incompatibility through blood typing and crossmatching. Additional tests may include direct antiglobulin testing (Coombs test) to identify antibody-mediated destruction of red blood cells.

Treatment Options

Treatment focuses on stopping the transfusion immediately, managing hemodynamic instability (e.g., fluids, vasopressors), and addressing hemolysis (e.g., diuretics, alkalinization of urine). Supportive care may include oxygen therapy, monitoring for organ dysfunction, and administering medications to mitigate immune reactions (e.g., corticosteroids).

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Mild cases may resolve with supportive care, while severe reactions can lead to acute kidney injury, shock, or death. Follow-up includes monitoring for delayed complications (e.g., renal impairment) and ensuring proper blood product compatibility in future transfusions.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or hypotension
• Respiratory distress or acute lung injury
• Neurological complications (e.g., stroke)
• Multi-organ failure in severe cases

Lifestyle & Prevention

Prevention relies on strict adherence to blood typing, crossmatching, and verification protocols before transfusion. Healthcare providers should ensure accurate labeling of blood products and confirm compatibility with the recipient. Patients with known antibodies or sensitivities may require specialized blood products.

When to Seek Professional Help

Seek immediate medical attention if symptoms of a transfusion reaction occur, such as fever, chills, pain, or changes in urine color, during or after a blood transfusion. Prompt evaluation is critical to minimize complications.

Tips for Medical Coders

Code T80.39 is used for other specified ABO incompatibility reactions due to transfusion of blood or blood products. Documentation should specify the type of reaction (e.g., non-hemolytic, febrile) and confirm the transfusion context. Ensure the code aligns with clinical findings and avoids overlap with more specific codes (e.g., hemolytic transfusion reactions).